Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Declan G Murphy

Showing results (21-30 of 414) with videos related to

Pageof 42
Sort By:
Nature Reviews. Urology|September 21, 2016
Planning for the post-antibiotic era - why we must avoid TRUS-guided biopsy samplingDeclan G Murphy, Jeremy P Grummet
European Urology|January 8, 2013
Focal therapy in the treatment of localised prostate cancer: primum non nocereBen J Challacombe, Declan G Murphy
The Medical Journal of Australia|July 13, 2010
Has PSA testing truly been a "public health disaster"?Anthony J Costello, Declan G Murphy
European Urology|April 24, 2013
Words of wisdom. Re: Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)James B Duthie, Declan G Murphy
BJU International|September 14, 2013
Comparative assessment of three standardized robotic surgery training methodsDeclan G Murphy, Chandru P Sundaram
European Urology|January 15, 2015
Words of wisdom. Re: Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-upSimon van Rij, Declan G Murphy
European Urology Focus|July 21, 2017
Case Discussion: Intermediate-risk Prostate Cancer: The Case for Radical TreatmentSiska Van Bruwaene, Declan G Murphy
European Urology|July 4, 2020
Focal Therapy: When Nothing Is Sure, Everything Is PossibleMarcus G Cumberbatch, Declan G Murphy
International Journal of Urology : Official Journal of the Japanese Urological Association|July 7, 2015
Editorial Comment to Current use of active surveillance for localized prostate cancer: A nationwide survey in JapanSiska Van Bruwaene, Declan G Murphy
The Medical Journal of Australia|May 12, 2021
Differences in treatment choices for localised prostate cancer diagnosed in private and public health servicesHenry H Woo, Declan G Murphy
Pageof 42

Showing results (21-30 of 414) with videos related to

Sort By:
Pageof 42
Nature Reviews. Urology|September 21, 2016
Planning for the post-antibiotic era - why we must avoid TRUS-guided biopsy samplingDeclan G Murphy, Jeremy P Grummet
European Urology|January 8, 2013
Focal therapy in the treatment of localised prostate cancer: primum non nocereBen J Challacombe, Declan G Murphy
The Medical Journal of Australia|July 13, 2010
Has PSA testing truly been a "public health disaster"?Anthony J Costello, Declan G Murphy
European Urology|April 24, 2013
Words of wisdom. Re: Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)James B Duthie, Declan G Murphy
BJU International|September 14, 2013
Comparative assessment of three standardized robotic surgery training methodsDeclan G Murphy, Chandru P Sundaram
European Urology|January 15, 2015
Words of wisdom. Re: Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-upSimon van Rij, Declan G Murphy
European Urology Focus|July 21, 2017
Case Discussion: Intermediate-risk Prostate Cancer: The Case for Radical TreatmentSiska Van Bruwaene, Declan G Murphy
European Urology|July 4, 2020
Focal Therapy: When Nothing Is Sure, Everything Is PossibleMarcus G Cumberbatch, Declan G Murphy
International Journal of Urology : Official Journal of the Japanese Urological Association|July 7, 2015
Editorial Comment to Current use of active surveillance for localized prostate cancer: A nationwide survey in JapanSiska Van Bruwaene, Declan G Murphy
The Medical Journal of Australia|May 12, 2021
Differences in treatment choices for localised prostate cancer diagnosed in private and public health servicesHenry H Woo, Declan G Murphy
Pageof 42